Connect with us

Hi, what are you looking for?


Peso gains on vaccine progress in US, UK

THE PESO strengthened anew against the greenback on Wednesday, backed by hopes of positive vaccine developments in the United States and the United Kingdom.

The local unit finished trading at P48.05 per dollar on Wednesday, gaining three centavos from its close of P48.08 on Monday, data from the Bankers Association of the Philippines showed.

The peso opened Wednesday’s session at P48.12 versus the greenback. Its weakest showing was at P48.125, while its closing level was its intraday best.

Dollars traded dropped to $505.8 million yesterday from $539.45 million on Monday.

News related to vaccines resulted in risk-off sentiment that benefited the peso, analysts said.

Rizal Commercial Banking Corp. Chief Economist Michael L. Ricafort said the vaccine progress in the UK made market sentiment upbeat.

On Tuesday, 90-year-old Margaret Keenan became the world’s first person to receive a vaccine shot in central England, Reuters reported. The United Kingdom is the first globally to kick off mass vaccinations and administer a shot developed by Pfizer, Inc. and BioNTech SE.

Meanwhile, the trader cited new findings in the US about Pfizer’s vaccine.

“The peso strengthened anew from market optimism after the US Food and Drug Administration (FDA) noted that the Pfizer vaccine does not have any untoward findings for its emergency use application,” the trader said in an e-mail.

The US FDA gave its seal of approval to the firm on Tuesday and released documents showing there were no issues relating to safety or efficacy from emergency use of the vaccine.

For today, the peso is seen declining against the dollar ahead of the European Central Bank’s policy review.

“The local currency might depreciate [this Thursday] amid expectations of dovish guidance from the European Central Bank tomorrow as the policy-setting authority is expected to provide details in its asset purchases program from its December meeting,” the trader said.

Mr. Ricafort gave a forecast range of P48.00 to P48.10 per dollar. — L.W.T. Noble with Reuters

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!



THE PESO strengthened against the dollar on Tuesday amid easing global oil prices and ahead of an expected increase in remittances due to the...


PHILIPPINE STOCKS extended their climb on Tuesday on last-minute bargain-hunting and ahead of the rebalancing of the MSCI. The bellwether Philippine Stock Exchange index...


THE government financial institutions (GFIs) that will be tapped to provide capital and help manage a P250-billion sovereign wealth fund have disclosed their proposed...


THE European Chamber of Commerce of the Philippines (ECCP) urged the Philippines to eliminate tariffs on imports of all electric vehicles (EVs) regardless of...


PRESIDENT Ferdinand R. Marcos, Jr. is expected to sign an executive order (EO) that will fast-track applications for investments deemed strategic to the economy,...


AN Israeli tech investor said a country’s legal system is a major consideration in attracting foreign investment, and urged legislators to reform the tax...

You May Also Like


The minute that any question pops into your head, you can simply ask Google. No longer do we have to pour over books and...


Having a good Instagram marketing agency to back up your Instagram account is an absolute must going into the new year. With competition stronger...


Browsing history makes referring to sites and pages you’ve visited in the past seamless. It’ll help you recall what page you checked out on...


Insomnia is the most common sleep disorder in the global population. Therefore, it is a problem that many people suffer or have suffered throughout...

Disclaimer:, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 SmartRetirementReport. All Rights Reserved.